Thursday | 8 January, 2009
Australian Biotechnology News

Stories about: BRAIN RESOURCE COMPANY

  • +

    BRC branches into MS 08/02/2006 14:56:13

    The Brain Resource Company (ASX:BRC) is to supply its services to a Schering Israel funded Multiple Sclerosis study.
  • +

    BRC earns US marketing approval 28/10/2005 14:23:45

    The Brain Resource Company (ASX:BRC) has been granted approval from the US FDA to market its methodology and standardised international human brain database.
  • +

    In brief: Psivida, Eqitx, Ellex, BRC, AFT 26/07/2005 14:19:04

    Following its recent Nasdaq listing, Psivida (ASX:PSD, NASDAQ:PSDV, Xetra:PSI) has appointed the president and CEO of New Jersey-based Chugai Pharma USA, David J Mazzo, as a non-executive director.
  • +

    BRC lands Glaxo contract 05/05/2005 15:08:11

    GlaxoSmithKline Research and Development is to buy two Brain Resource Laboratories from Sydney-based brain function databasecompiler Brain Resource Company (ASX:BRC), for operation at Quintiles' Guys Drug Research Unit in London.
  • +

    Brain Resource Company raises $4 million, plans marketing push 19/11/2003 13:49:07

    Sydney-based Brain Resource Company (ASX: BRC) has completed an AUD$4 million placement to institutional investors, giving it the funding to back a marketing push for its brain imaging and functional testing products and services.
  • +

    Biogen using Brain Resource Co platform 10/10/2003 13:31:11

    Sydney-based Brain Resource Company (ASX:BRC) has cracked into the biotechnology sector with a deal to provide its profiles of brain function and cognition to Biogen in the United States.
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
 
Sponsored Links